These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

992 related items for PubMed ID: 16771614

  • 1. Valacyclovir for the treatment of genital herpes.
    Brantley JS, Hicks L, Sra K, Tyring SK.
    Expert Rev Anti Infect Ther; 2006 Jun; 4(3):367-76. PubMed ID: 16771614
    [Abstract] [Full Text] [Related]

  • 2. Valacyclovir in the treatment of genital herpes and herpes zoster.
    Baker DA.
    Expert Opin Pharmacother; 2002 Jan; 3(1):51-8. PubMed ID: 11772333
    [Abstract] [Full Text] [Related]

  • 3. Valacyclovir in the treatment of herpes simplex, herpes zoster, and other viral infections.
    Wu JJ, Brentjens MH, Torres G, Yeung-Yue K, Lee P, Tyring SK.
    J Cutan Med Surg; 2003 Jan; 7(5):372-81. PubMed ID: 14505192
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV.
    Warren T, Harris J, Brennan CA.
    Clin Infect Dis; 2004 Nov 01; 39 Suppl 5():S258-66. PubMed ID: 15494897
    [Abstract] [Full Text] [Related]

  • 5. Valacyclovir. New indication: for genital herpes, simpler administration.
    Can Fam Physician; 1999 Jul 01; 45():1698-700, 1703-5. PubMed ID: 10424269
    [Abstract] [Full Text] [Related]

  • 6. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
    Tyring SK, Baker D, Snowden W.
    J Infect Dis; 2002 Oct 15; 186 Suppl 1():S40-6. PubMed ID: 12353186
    [Abstract] [Full Text] [Related]

  • 7. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH, Warren TJ, Justus SE, Heitman CK, HS2100275 STUDY TEAM.
    Sex Transm Dis; 2008 Jul 15; 35(7):668-73. PubMed ID: 18461016
    [Abstract] [Full Text] [Related]

  • 8. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
    Bavaro JB, Drolette L, Koelle DM, Almekinder J, Warren T, Tyring S, Wald A.
    Sex Transm Dis; 2008 Apr 15; 35(4):383-6. PubMed ID: 18362859
    [Abstract] [Full Text] [Related]

  • 9. Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment.
    Leone PA, Trottier S, Miller JM.
    Clin Infect Dis; 2002 Apr 01; 34(7):958-62. PubMed ID: 11880962
    [Abstract] [Full Text] [Related]

  • 10. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
    Handsfield HH, Warren T, Werner M, Phillips JA.
    Sex Transm Dis; 2007 Jun 01; 34(6):339-43. PubMed ID: 17065847
    [Abstract] [Full Text] [Related]

  • 11. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
    Fife KH, Warren TJ, Ferrera RD, Young DG, Justus SE, Heitman CK, Burroughs SM.
    Mayo Clin Proc; 2006 Oct 01; 81(10):1321-7. PubMed ID: 17036557
    [Abstract] [Full Text] [Related]

  • 12. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
    Sperling RS, Fife KH, Warren TJ, Dix LP, Brennan CA.
    Sex Transm Dis; 2008 Mar 01; 35(3):286-90. PubMed ID: 18157071
    [Abstract] [Full Text] [Related]

  • 13. Comparative bioavailability of acyclovir from oral valacyclovir and acyclovir in patients treated for recurrent genital herpes simplex virus infection.
    Bras AP, Sitar DS, Aoki FY.
    Can J Clin Pharmacol; 2001 Mar 01; 8(4):207-11. PubMed ID: 11743593
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of safety and efficacy of prolonged suppressive therapy of genital herpes with valacyclovir.
    Durglishvili N, Shishniashvili D, Kvirkvelia V.
    Georgian Med News; 2009 Mar 01; (172-173):47-9. PubMed ID: 19644189
    [Abstract] [Full Text] [Related]

  • 15. Valacyclovir for the suppression of recurrent genital herpes in human immunodeficiency virus-infected subjects.
    DeJesus E, Wald A, Warren T, Schacker TW, Trottier S, Shahmanesh M, Hill JL, Brennan CA, Valacyclovir International HSV Study Group.
    J Infect Dis; 2003 Oct 01; 188(7):1009-16. PubMed ID: 14513421
    [Abstract] [Full Text] [Related]

  • 16. Reducing the risk of transmitting genital herpes: advances in understanding and therapy.
    Leone P.
    Curr Med Res Opin; 2005 Oct 01; 21(10):1577-82. PubMed ID: 16238897
    [Abstract] [Full Text] [Related]

  • 17. Single-day, patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: a randomized, double-blind, comparative trial.
    Abudalu M, Tyring S, Koltun W, Bodsworth N, Hamed K.
    Clin Infect Dis; 2008 Sep 01; 47(5):651-8. PubMed ID: 18637755
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
    Gupta R, Wald A, Krantz E, Selke S, Warren T, Vargas-Cortes M, Miller G, Corey L.
    J Infect Dis; 2004 Oct 15; 190(8):1374-81. PubMed ID: 15378428
    [Abstract] [Full Text] [Related]

  • 20. Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients.
    Le Cleach L, Trinquart L, Do G, Maruani A, Lebrun-Vignes B, Ravaud P, Chosidow O.
    Cochrane Database Syst Rev; 2014 Aug 03; 2014(8):CD009036. PubMed ID: 25086573
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.